Company & Sponsor Intelligence

Seoul National University Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials10

Recruiting1

Completed4

Countries1

Therapeutic footprint

adhdalzheimersneuroimmunologyother_neurologyparkinsonsstroke

Indexed studies

NCT01564316Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients
other_neurology · South KoreaTERMINATED

NCT01313819The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy
parkinsons · South KoreaPHASE4

NCT04830631tDCS Response Prediction Using EEG in Stroke
stroke · South KoreaUNKNOWN

NCT02714959IL-2 in Refractory Autoimmune Encephalitis
neuroimmunology · PHASE1, PHASE2

NCT05302362Effect of Fixed vs. Tailored Intensity tDCS for Attention Deficit After TBI
adhd · South KoreaNA

NCT01338662Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist
parkinsons · South KoreaUNKNOWN

NCT01874418Biomarker Study to Diagnose Alzheimer's Disease
alzheimers · South KoreaNA

NCT05138263Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 (KBASE2)
alzheimers · South KoreaACTIVE_NOT_RECRUITING

NCT05148052Effect of Upper Extremity Rehabilitation Using Immersive Virtual Reality in Chronic Stroke Patients.
stroke · South KoreaNA

NCT03022201Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease
parkinsons · South KoreaPHASE4

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →